Among 53 BC patients, 74% had SGSM2 mRNA expression in tumours that was higher than that in normal tissue (T > N, n = 39), but in 26% of patients, SGSM2 mRNA expression in tumour tissue was less than that in normal tissue (N > T, n = 14). Here, SGSM2 is linked to breast cancer.